Table 2.
IL-29 expression and clinical baseline characteristics of CHD patients
| Clinical pathological features |
IL-29 | P | |
|---|---|---|---|
| Low level (N = 45) |
High level (N = 45) |
||
| Age (years) | 62.27 ± 8.18 | 60.44 ± 7.56 | 0.275a |
| Gender (male) | 29 (64.4%) | 24 (53.3%) | 0.284b |
| BMI (kg/m 2 ) | 23.38 ± 1.44 | 23.43 ± 1.32 | 0.888a |
| Hypertension | 21 (46.7%) | 20 (44.4%) | 0.832b |
| TC (mmol/L) | 4.62 ± 0.75 | 4.63 ± 0.76 | 0.963a |
| TG (mmol/L) | 1.44 ± 0.51 | 1.28 ± 0.44 | 0.106a |
| HDL-c (mmol/L) | 1.24 ± 0.27 | 1.21 ± 0.25 | 0.525a |
| LDL-c (mmol/L) | 2.56 ± 0.39 | 2.52 ± 0.40 | 0.599a |
| Smoking, Current | 28 (62.2%) | 21 (46.7%) | 0.138b |
| Drinking, Current | 24 (53.3%) | 27 (60.0%) | 0.523b |
| Diabetes | 15 (33.3%) | 17 (37.8%) | 0.660b |
| SNYTAX score | 20.89 ± 6.61 | 26.42 ± 7.18 | < 0.001a |
| CRP (mg/L) | 8.77 ± 2.44 | 9.97 ± 3.10 | 0.043a |
Note: CHD, coronary heart disease; BMI, body mass index; TC, total cholesterol; TG, triglyceride; HDL-c, high-density lipoprotein-cholesterol; LDL-c, low-density lipoprotein-cholesterol; CRP, C-reactive protein